Clarithromycin in early pregnancy and the risk of miscarriage and malformation: a register based nationwide cohort study

Abstract

Background: The antibiotic clarithromycin has been associated with fetal loss in animals and a study has found a doubling in the frequency of miscarriages among women using clarithromycin in pregnancy. The aim of the study was to investigate whether clarithromycin use in early pregnancy was associated with an increased risk for miscarriages and major malformations.

Methods: We conducted a nationwide cohort study including all women in Denmark with a known conception between 1997 and 2007. The Fertility Database was used to identify all women giving birth and the National Hospital Register was used to identify all women with a record of miscarriage or induced abortion. Prescription data was obtained from the National Prescription Register. The primary outcome was the number of miscarriages and offspring with major congenital malformations among users of clarithromycin compared to non-users.

Results: We identified 931 504 pregnancies (705 837 live births, 77 553 miscarriages, and 148 114 induced abortions). 401 women redeemed a prescription of clarithromycin in the first trimester of which 40 (10.0%) experienced a miscarriage and among the live born nine (3.6%) had offspring with malformations. The hazard ratio (HR) of having a miscarriage after exposure to clarithromycin was 1.56 (CI95% 1.14-2.13). There was no increased hazard of having a miscarriage when being exposed to penicillin or erythromycin. There was no increased prevalence (OR = 1.03 (CI95% 0.52-2.00)) of having offspring with malformations after exposure to clarithromycin.

Conclusions: We found an increased hazard of miscarriage but no increased prevalance of having offspring with malformations among women redeeming a prescription of clarithromycin in early pregnancy. This is supported by previous studies in animals and humans. However, further research is required to explore the possible effect of treatment indication on the associations found.

Figure 1. The hazard ratio of having a miscarriage when redeeming a prescription of a drug in the first trimester of pregnancy.

All hazards are adjusted for age, parity, educational level, and income. *Proton pump inhibitors.

Figure 2. The hazard ratio of having a miscarriage when redeeming a prescription of clarithromycin in the first trimester of pregnancy directly compared to the hazard of women redeeming prescriptions of different drugs used in similar conditions.

All hazards are adjusted for age, parity, educational level, and income. *Proton pump inhibitors.